Cargando…
Early knee OA definition–what do we know at this stage? An imaging perspective
While criteria for early-stage knee osteoarthritis (OA) in a primary care setting have been proposed, the role of imaging has been limited to radiography using the standard Kellgren–Lawrence classification. Standardized imaging and interpretation are critical with radiographs, yet studies have also...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017942/ https://www.ncbi.nlm.nih.gov/pubmed/36937824 http://dx.doi.org/10.1177/1759720X231158204 |
_version_ | 1784907701781790720 |
---|---|
author | Li, Xiaojuan Roemer, Frank W. Cicuttini, Flavia MacKay, Jamie W. Turmezei, Tom Link, Thomas M. |
author_facet | Li, Xiaojuan Roemer, Frank W. Cicuttini, Flavia MacKay, Jamie W. Turmezei, Tom Link, Thomas M. |
author_sort | Li, Xiaojuan |
collection | PubMed |
description | While criteria for early-stage knee osteoarthritis (OA) in a primary care setting have been proposed, the role of imaging has been limited to radiography using the standard Kellgren–Lawrence classification. Standardized imaging and interpretation are critical with radiographs, yet studies have also shown that even early stages of radiographic OA already demonstrate advanced damage to knee joint tissues such as cartilage, menisci, and bone marrow. Morphological magnetic resonance imaging (MRI) shows degenerative damage earlier than radiographs and definitions for OA using MRI have been published though no accepted definition of early OA based on MRI is currently available. The clinical significance of structural abnormalities has also not been well defined, and the differentiation between normal aging and structural OA development remains a challenge. Compositional MRI of cartilage provides information on biochemical, degenerative changes within the cartilage matrix before cartilage defects occur and when cartilage damage is potentially reversible. Studies have shown that cartilage composition can predict cartilage loss and radiographic OA. However, while this technology is most promising for characterizing early OA it has currently limited clinical application. Better standardization of compositional MRI is required, which is currently work in progress. Finally, there has been renewed interest in computed tomography (CT) for assessing early knee OA as new techniques such as weight bearing and spectral CT are available, which may provide information on joint loading, cartilage, and bone and potentially have a role in better characterizing early OA. In conclusion, while imaging may have a limited role in diagnosing early OA in a primary care setting, there are advanced imaging technologies available, which detect early degeneration and may thus significantly alter management as new therapeutic modalities evolve. |
format | Online Article Text |
id | pubmed-10017942 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-100179422023-03-17 Early knee OA definition–what do we know at this stage? An imaging perspective Li, Xiaojuan Roemer, Frank W. Cicuttini, Flavia MacKay, Jamie W. Turmezei, Tom Link, Thomas M. Ther Adv Musculoskelet Dis Addressing the Challenges Associated with the Development, Testing and Approval of Novel Therapeutics for Osteoarthritis While criteria for early-stage knee osteoarthritis (OA) in a primary care setting have been proposed, the role of imaging has been limited to radiography using the standard Kellgren–Lawrence classification. Standardized imaging and interpretation are critical with radiographs, yet studies have also shown that even early stages of radiographic OA already demonstrate advanced damage to knee joint tissues such as cartilage, menisci, and bone marrow. Morphological magnetic resonance imaging (MRI) shows degenerative damage earlier than radiographs and definitions for OA using MRI have been published though no accepted definition of early OA based on MRI is currently available. The clinical significance of structural abnormalities has also not been well defined, and the differentiation between normal aging and structural OA development remains a challenge. Compositional MRI of cartilage provides information on biochemical, degenerative changes within the cartilage matrix before cartilage defects occur and when cartilage damage is potentially reversible. Studies have shown that cartilage composition can predict cartilage loss and radiographic OA. However, while this technology is most promising for characterizing early OA it has currently limited clinical application. Better standardization of compositional MRI is required, which is currently work in progress. Finally, there has been renewed interest in computed tomography (CT) for assessing early knee OA as new techniques such as weight bearing and spectral CT are available, which may provide information on joint loading, cartilage, and bone and potentially have a role in better characterizing early OA. In conclusion, while imaging may have a limited role in diagnosing early OA in a primary care setting, there are advanced imaging technologies available, which detect early degeneration and may thus significantly alter management as new therapeutic modalities evolve. SAGE Publications 2023-03-14 /pmc/articles/PMC10017942/ /pubmed/36937824 http://dx.doi.org/10.1177/1759720X231158204 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Addressing the Challenges Associated with the Development, Testing and Approval of Novel Therapeutics for Osteoarthritis Li, Xiaojuan Roemer, Frank W. Cicuttini, Flavia MacKay, Jamie W. Turmezei, Tom Link, Thomas M. Early knee OA definition–what do we know at this stage? An imaging perspective |
title | Early knee OA definition–what do we know at this stage? An imaging perspective |
title_full | Early knee OA definition–what do we know at this stage? An imaging perspective |
title_fullStr | Early knee OA definition–what do we know at this stage? An imaging perspective |
title_full_unstemmed | Early knee OA definition–what do we know at this stage? An imaging perspective |
title_short | Early knee OA definition–what do we know at this stage? An imaging perspective |
title_sort | early knee oa definition–what do we know at this stage? an imaging perspective |
topic | Addressing the Challenges Associated with the Development, Testing and Approval of Novel Therapeutics for Osteoarthritis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017942/ https://www.ncbi.nlm.nih.gov/pubmed/36937824 http://dx.doi.org/10.1177/1759720X231158204 |
work_keys_str_mv | AT lixiaojuan earlykneeoadefinitionwhatdoweknowatthisstageanimagingperspective AT roemerfrankw earlykneeoadefinitionwhatdoweknowatthisstageanimagingperspective AT cicuttiniflavia earlykneeoadefinitionwhatdoweknowatthisstageanimagingperspective AT mackayjamiew earlykneeoadefinitionwhatdoweknowatthisstageanimagingperspective AT turmezeitom earlykneeoadefinitionwhatdoweknowatthisstageanimagingperspective AT linkthomasm earlykneeoadefinitionwhatdoweknowatthisstageanimagingperspective |